In this study, we mainly focused on clarifying the mechanism by which MYC regulates the cell proliferation of DLBCL via the NEAT1-miR-34b-5p-GLI1 signaling axis, which might provide novel targets for DLBCL therapies. Here, GLI1 is linked to diffuse large B-cell lymphoma.